Subacute prosthetic aortic endocarditis caused by Actinotignum schaalii: a rare but destructive pathogen – case report and literature review Authors: Benoit Rallet, Marie-Catherine Morgant, Thibault Lelercq, Stephanie Honore, Meriam Romdhani, Lionel Piroth, Mathieu Blot, Thibault Sixt Published: 2025 ABSTRACT AbstractBackgroundActinotignum schaalii is an emerging urogenital pathogen rarely reported as a cause of endocarditis.Case presentationA 54-year-old man developed recurrent embolic strokes seven and eight years post-Bentall procedure with mechanical aortic valve. Blood cultures grew Gram-positive bacilli, initially misidentified as Corynebacterium spp., later confirmed as Actinotignum schaalii. Cardiac CT revealed a 12 mm × 15 mm × 20 mm perivalvular abscess fistulizing into the sinus of Valsalva and prosthetic graft. 18 F-FDG PET/CT confirmed intense hypermetabolism around the prosthesis. Despite targeted amoxicillin therapy, intraoperative exploration revealed complete Bentall conduit dehiscence from extensive aorto-mitral trigone destruction. Reconstruction was deemed unfeasible, and the patient died following multidisciplinary decision to limit interventions. No urological source was identified.ConclusionsActinotignum schaalii can cause indolent prosthetic valve endocarditis with devastating perivalvular complications. Prolonged blood culture incubation is crucial for early diagnosis in patients with prosthetic material and unexplained embolic events.Clinical trialNot applicable.Keywords: Actinotignum schaalii, Actinobaculum schaalii, Infectious endocarditis, Vascular prosthesis, Cardiac surgery Introduction The genus Actinotignum comprises five species, including Actinotignum schaalii (formerly Actinobaculum schaalii), a Gram-positive bacillus increasingly recognized as an emerging human pathogen. Although its natural reservoir remains uncertain, A. schaalii is considered a commensal of the urogenital tract [1] and is most commonly associated with urinary tract infections, particularly in elderly or urologically compromised patients [1]. It has also been implicated in bacteremia [2–4], while infections involving other anatomical sites, especially the cardiovascular system, remain rare. Here, we present a case of subacute infectious endocarditis on an aortic vascular prosthesis due to A. schaalii. We conducted a comprehensive literature review to identify all reported cases of Actinotignum schaalii endocarditis. Searches were performed in PubMed and Google Scholar using the keywords: “Actinobaculum schaalii”, “Actinotignum schaalii”, “infective endocarditis”, “vascular prosthesis”, and “cardiac surgery”, applied to titles, abstracts, and Medical Subject Headings (MeSH), without restrictions on publication date or language. Case presentation (timeline available in Fig. 1) Timeline of clinical events and interventions A 54-year-old man with no significant past medical history underwent a Bentall procedure with a mechanical valve to treat aortic insufficiency associated with an ascending aortic aneurysm and localized dissection. The immediate postoperative course was uneventful. Seven years later, he presented to the emergency department of Dijon University Hospital with decreased visual acuity and bitemporal hemianopia, in the context of subtherapeutic anticoagulation. Biological investigations revealed anemia with a hemoglobin level of 10.7 g/dL (normal > 13 g/dL) and a moderate elevation of C-reactive protein (CRP) at 39.5 mg/L (normal < 4 mg/L), while the leukocyte count remained within the normal range. Brain magnetic resonance imaging (MRI) revealed bilateral posterior ischemic stroke associated with posterior cerebral artery stenosis. thoracic echocardiography, coronarography and computed tomography (CT) demonstrated a large aneurysm of the left coronary ostium measuring 94 mm × 53 mm, involving the left atrium and suggestive of disjunction at the left coronary trunk anastomosis. Surgical reintervention was performed to reimplant the left coronary trunk into the aortic prosthesis. In the months following the second procedure, the patient reported recurrent episodes of chills and sweating, which he self-managed with non-steroidal anti-inflammatory drugs and paracetamol. No medical evaluation was sought at this stage. More than a year later, the patient was readmitted to the emergency department of Auxerre Hospital, France. Over a three-week period prior to admission, he had experienced four episodes of right-sided hemiparesis, each resolving spontaneously and completely within a few hours. These episodes were associated with chills and a subjective sensation of fever, although his temperature was not recorded at home. He also reported persistent fatigue, but denied anorexia or weight loss. Laboratory tests showed a white blood cell count of 6.9 × 10⁹/L (normal: 4–11) and an elevated C-reactive protein (CRP) level of 50 mg/L (normal < 3.3). Anemia with a hemoglobin level of 9.4 g/dL (normal > 13 g/dL) and hypoalbuminemia at 25 g/L (normal > 34 g/L) were also noted. Brain MRI revealed a recent ischemic stroke in the left cerebellopontine region, along with chronic ischemic sequelae in the cerebellum and left frontal lobe (Fig. 2). Axial T2 FLAIR brain MRI demonstrating an embolic lesion in the left cerebellopontine region Blood cultures became positive after nine days, revealing a Gram-positive bacillus on direct examination, initially identified as Corynebacterium spp. using the Vitek® 2 ID ANC system. Transthoracic and transesophageal echocardiography revealed a large pseudoaneurysm of the ascending aorta but showed no definitive vegetations or valvular involvement. An 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT) scan demonstrated intense heterogeneous hypermetabolism (SUV 5.1) around the aortic prosthesis (Fig. 3), strongly suggestive of prosthetic infective endocarditis. A: Sagittal view of the Positive Emission Tomography Scanner showing an intense circumferential hypermetabolism (SUV 5.1) around the aortic prosthesis. B: Axial view of the Positive Emission Tomography Scanner showing an intense circumferential hypermetabolism (SUV 5.1) around the aortic prosthesis Empiric intravenous antibiotic therapy with amoxicillin (12 g/day), cloxacillin (12 g/day), and gentamicin (240 mg/day) was initiated for suspected but undocumented infective endocarditis. Given the possible diagnosis of prosthetic material–related infective endocarditis, not yet documented, the patient was transferred to the University Hospital of Dijon for further management. Upon admission, a retrospective review of the medical record revealed that a single intraoperative sample obtained from the pseudoaneurysm in 2023 had grown A. schaalii on standard culture, while enrichment culture remained negative. The isolate was identified by MALDI-TOF mass spectrometry using the IVD MALDI Biotyper system (Bruker Daltonics, Bremen, Germany) with the MBT IVD Library, Revision G (2021), but was initially considered a contaminant due to its isolated occurrence. Following consultation with the microbiologists from Auxerre regarding the 2023 identification, and reinterpretation of the previous blood culture results using the Vitek® 2 ANC identification system (applied in this context due to the unavailability of MALDI-TOF for blood culture isolates), A. schaalii was confirmed from blood cultures with a 97% probability. Antibiotic therapy was subsequently narrowed to intravenous amoxicillin monotherapy (12 g/day) based on the antibiogram performed using the Vitek system in liquid medium, which showed a minimum inhibitory concentration (MIC) of 0.125 µg/mL for amoxicillin. A new transoesophageal echocardiogram (TEE) revealed that the aortic valve was very difficult to visualize. A minimal paravalvular leak was identified, along with major periprosthetic tissue alterations and evidence of periprosthetic abscesses. Subsequent cardiac CT revealed a 12 mm × 15 mm × 20 mm abscess in the posterior left ventricular outflow tract, fistulizing into the sinus of Valsalva and the posterior segment of the prosthetic graft (Fig. 4). A: Sagittal CT view showing a peri-prosthetic abscess located beneath the left main coronary trunk and over the proximal portion of the aortic graft. B: CT scan (LVOT view) showing an abscess in the left ventricular outflow tract. C: Axial computed tomography (CT) view revealing a peri-prosthetic abscess located in the left ventricular outflow tract (LVOT). D: Axial CT image demonstrating fistulous extension of a peri-graft abscess surrounding the prosthetic anchoring struts A third surgical intervention was planned to replace the entire prosthetic assembly. Intraoperative exploration revealed severe inflammatory adhesions involving the ascending aorta, aortic root, and surrounding cardiac structures. A large circumferential pseudoaneurysm, secondary to an abscess at the aorto-mitral trigone, had led to complete dehiscence of the Bentall conduit with massive bleeding, rendering aortic clamping impossible. The extent of tissue destruction was so extensive that reconstruction of the aortic root and the mitro-aortic trigone was deemed unfeasible. Following a collegial multidisciplinary discussion, a decision was made to limit therapeutic interventions in light of the irreversible surgical impasse. Notably, no history of urinary tract infection or urological procedures was documented during the clinical course. Urinary cultures remained sterile. Although the patient had a recent tooth extraction, this was considered unrelated to the infection due to the urinary tropism of A. schaalii, which is not a commensal of the oral cavity. Discussion and conclusion In the literature, A. schaalii is mainly recognized as an emerging urinary pathogen [5] but is increasingly linked to invasive infections such as bacteremia, including severe forms like septic shock [2, 3]. This case highlights the pathogen’s ability to cause deep-seated, severe infections beyond its common role in urinary tract infections. Our review (Table 1) found only four documented cases of A. schaalii endocarditis, predominantly affecting the left heart [6–9]. Table 1Summary of reported cases of endocarditis caused by Actinobaculum Schaali or Actinotignum SchaaliReferencePublication yearAge, sexComorbiditiesUrinary tract interventionValve typeLocation of infected valveLocal complicationSystemic complicationSurgeryAntibioticsDuration (days)OutcomeHoenigl et al. [6]201052, maleStroke, mechanical aortic valve replacement (2 years prior), gastric-duodenal angiodysplasiaNoProstheticAorticNoNoNoAmoxicillin + clavulanic acid56ImprovedK. Diallo et al. [7], 201863, maleNone reportedYesNativeAortic/tricuspidNoNoYesAmoxicillin + Gentamicin28Improved A. Premkrumar et al. [8], 202286, femaleAdvanced dementiaNoNativeMitralNoYesNoCeftriaxoneNot reportedDiedC. Loïez et al. [9], 201889, maleNone reportedNoNativeAorticNoNoYesAmoxicillinNot reportedImprovedOur case202562, maleAortic prosthesis (Bentall procedure) for aortic insufficiency with aortic dissection, coronary artery disease, recent tooth extractionNoProstheticAorticAbscessNoYesAmoxicillin8Died Summary of reported cases of endocarditis caused by Actinobaculum Schaali or Actinotignum Schaali This underscores the need to consider this pathogen even outside typical clinical presentations. A. schaalii was identified in the blood cultures of all four cases, and in the urinary cultures of two patients [7, 8]. Two patients required valve surgery [7, 9], and only one had undergone urinary tract surgery [7]. Unlike previously reported acute cases without major local complications, our case presented as a prolonged, low-grade infection with extensive tissue destruction. This chronicity suggests low virulence but with a propensity for significant local damage. This is the second case involving prosthetic material [6], suggesting an ability to adhere to foreign bodies, a crucial consideration in patients with implanted devices. A fatal outcome is not uncommon in such cardiac manifestations, with one death reported in the literature [8] and another in our case. This supports the potential for severe infection associated with this pathogen, as previously suggested in the literature [10] and the need for heightened vigilance in cases of cardiac involvement. Although the urinary tract is the usual presumed source [11], it was not identified in this case, nor in three of the four previously reported cases [6, 8, 9]. However, it is important to note that specific investigations of the urinary tract may not always have been systematically performed. Moreover, while A. schaalii grows poorly on standard culture media and is therefore frequently missed, it has been recovered from urine cultures in some studies [2, 11, 12]. However, since routine urine cultures are not performed under anaerobic conditions, A. schaalii is usually not isolated in standard microbiological practice. In our patient, a recent tooth extraction was reported, but this is unlikely to be related to the source of infection, as A. schaalii is not a commensal of the oral cavity. We hypothesize that the anastomotic disjunction in this patient was more likely related to infection rather than the second surgical intervention, as nosocomial A. schaalii infections have not been reported. A. schaalii is a slow-growing Gram-positive bacillus that requires enriched culture media for optimal growth [7]. Its slow growth in blood cultures is clinically relevant, as routine incubation is often limited to 5 days. In cases of prosthetic valve endocarditis with no identified pathogen, extending the incubation period may facilitate the detection of A. schaalii and other slow-growing bacteria such as Cutibacterium acnes, a recognized cause of late-onset prosthetic valve endocarditis [13]. This protracted clinical course further supports the low-virulence profile of this organism. On direct examination, it can be readily mistaken for Corynebacterium spp., potentially leading to diagnostic confusion. Tuuminen et al. [14]. and Lieu et al. [4] have demonstrated that MALDI-TOF mass spectrometry outperforms 16 S rRNA PCR for species-level identification, making it a critical tool to ensure accurate diagnosis and prevent delays in treatment. Regarding antimicrobial susceptibility, Lotte et al. [12] reported low minimum inhibitory concentrations to beta-lactams. Other effective agents include glycopeptides, oxazolidinones, tetracyclines, rifamycins, and nitrofurans. Resistance to cotrimoxazole and second-generation quinolones is common, though newer fluoroquinolones often retain activity. Aminopenicillins remain the treatment of choice based on excellent in vitro activity (amoxicillin MIC₉₀ 0.25 mg/ml, 100% susceptibility) [5]. Use of amoxicillin–clavulanic acid has been described in one case report; however, the addition of clavulanic acid is unlikely to provide benefit, as beta-lactamase production has not been reported in A. schaalii [5]. For severe infections, initial combination therapy with an aminoglycoside may be considered due to the phylogenetic relationship with Actinomyces and possible beta-lactam tolerance [5], although successful outcomes with beta-lactam monotherapy have also been documented [9]. In conclusion, this case illustrates that A. schaalii is a rare but potential cause of severe prosthetic and endovascular infections beyond the urinary tract. This case highlights the importance of considering extended incubation in suspected prosthetic valve or vascular graft infections, particularly when initial cultures are negative despite strong clinical suspicion. Indeed, diagnosis was facilitated by prolonged blood culture incubation, exceeding the standard 5–7 days. Although often considered a contaminant due to its primary role as a uropathogen, its detection in patients with relevant cardiovascular history should trigger an in-depth diagnostic evaluation, including thorough microbiological work-up and imaging. Acknowledgements We thank Khadija ROMDHANI for her linguistic contribution. Abbreviations Actinotignum schaalii Computed Tomography C-reactive protein 18 F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fluid Attenuated Inversion Recovery Infective Endocarditis Left Ventricular Outflow Tract Matrix-Assisted Laser Desorption/Ionization – Time of Flight Medical Subject Headings Minimum Inhibitory Concentration Magnetic Resonance Imaging Author contributions Conceptualization: B.R., T.S.Literature review: B.R.Writing: B.R., T.S.Reviewing: M-C.M., T.L., S.H., M.R., L.P., M.B. Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Data availability The data that support the findings of this case report and literature review are available from the corresponding author upon reasonable request. Patient-level data cannot be shared publicly due to privacy and ethical restrictions. Declarations Ethics approval and consent to participate The patient was treated in accordance with the principles of the Helsinki Declaration, and the local ethics committee. Consent for publication Written informed consent for publication of clinical details and/or clinical images was obtained from patient’s next of kin. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The data that support the findings of this case report and literature review are available from the corresponding author upon reasonable request. Patient-level data cannot be shared publicly due to privacy and ethical restrictions.